Time trend of female breast carcinoma in situ by race and histology in Connecticut, U.S.A.

European Journal of Cancer Part A

Volumn 33, Issue 1, 1997, Pages 96-100

  Zheng, T ^a   Holford, T R ^a   Chen, Y ^a   Jones, B A ^a   Flannery, J ^b   Boyle, P ^c  

^a YALE UNIVERSITY   (United States)

^b Connecticut Tumor Registry ^*  (United States)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

breast carcinoma in situ; Connecticut; histology; incidence; time trend; U.S.A.

Indexed keywords

ARTICLE; BREAST CARCINOMA; CARCINOMA IN SITU; FEMALE; FUTUROLOGY; HISTOLOGY; HUMAN; PRIORITY JOURNAL; RACE; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CONNECTICUT; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED;

EID: 0031038496     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00371-1     Document Type: Article

References (22)

1. 1. Lantz PM, Remington PL, Newcomb PA. Mammography screening and increased incidence of breast cancer in Wisconsin. J Natl Cancer Inst 1991, 83, 1540-1546.
2. 2. Feuer EJ, Wu LM. How much of the recent rise in breast cancer incidence can be explained by increase in mammography utilization? Am J Epidemiol 1992, 136, 1423-1436.
3. 3. Miller BA, Feuer EJ, Hankey BF. The increasing incidence of breast cancer: relevance of early detection. Cancer Causes and Control 1991, 2, 67-74.
4. 4. Dodd GC. Screening for breast cancer. Cancer 1993, 72, 1038-1042.
5. 5. Breen N, Kassler L. Changes in the use of screening mammography: evidence from the 1987 and 1990 Health Interview Surveys. Am J Public Health 1994, 84, 62-67.
6. 6. Centers for Disease Control. Use of mammography: United States. Morb Mort Wkly Rep 1990, 39, 621-630.
7. 7. Dershaw D, Abraham A, Kinne DW. Ductal carcinoma in situ: mammographic findings and clinical implications. Radiology 1989, 170, 411-415.
8. 8. Schnitt SJ, Silen W, Sadowsky NL, Connolly JL, Harris JR. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med 1988, 318, 898-903.
9. 9. Eddy DM, Hasselblad V, Mogivney W, Hendee W. The value of mammography screening in women under age 50 years. JAMA 1988, 259, 1512-1519.
10. 10. Bailar JC. Mammography before age 50 years? JAMA 1988, 259, 1548-1549.
11. 11. Zheng T, Mayne ST, Boyle P, Holford TR, Liu W, Flannery J. Epidemiology of non-Hodgkin's lymphoma in Connecticut. Cancer 1992, 70, 840-849.
12. 12. Taylor VM, Taplin SH, Urban N, White E, Peacock S. Repeat mammography use among women ages 50-75. Cancer Epidemiol Biomark Prevent 1995, 4, 409-413.
13. 13. McWhorter WP, Eyre HJ. Impact of mammographic screening on breast cancer diagnosis. J Natl Cancer Inst 1990, 82, 153-154.
14. 14. Levi F, Te VC, La Vecchia C. Impact of mammography on breast cancer incidence in Vaud, Switzerland. J Natl Cancer Inst 1991, 83, 1181-1182.
15. 15. Glass AG, Hoover RN. Rising incidence of breast cancer: relationship to stage and receptor status. J Natl Cancer Inst 1990, 82, 693-696.
16. 16. Shapiro S, Venet W, Strax P, Venet L. Current results of the breast cancer screening randomized trial: the Health Insurance Plan (HIP) of Greater New York study. In Day NE, Miller AB, eds. Screening for Breast Cancer. Toronto, Canada, Hans Huber, 1988, 3-15.
17. 17. Chu KC, Smart CR, Tarone RE. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst 1988, 80, 1125-1131.
18. 18. Feig A. Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years. Cancer 1995, 75, 2412-2419.
19. 19. Seidman H, Gelb SK, Silberberg AA, La Verde N, Lubera J. Survival experience in the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1987, 37, 258-290.
20. 20. Smart CR, Hendrick RE, Rutledge JH III, Smith RA. Benefit of mammography screening in women aged 40-49: current evidence from randomized controlled trials. Cancer 1995, 75, 1619-1626.
21. 21. Feig SA. Assessment of radiation risk from screening mammography. Cancer 1996, 77, 818-822.
22. 22. Mettler FA, Upton AC, Kelsey CA, Ashby RN, Rosenberg RD, Linver MN. Benefits versus risks from mammography: a critical reassessment. Cancer 1996, 77, 903-909.